The Tissue Plasminogen Activator Market is Expected to be Flourished by Increasing Incidences of Cardiovascular Diseases

Tissue Plasminogen Activator Market


 Tissue plasminogen activator (tPA), also known as alteplase, is a thrombolytic agent or clot buster used to treat heart attacks and ischemic strokes. It works by breaking down or dissolving blood clots through the activation of plasminogen to form plasmin. tPA is administered intravenously within hours of the onset of stroke symptoms in order to minimize brain damage. It is indicated for the treatment of pulmonary embolism, myocardial infarction and ischemic stroke. The global tPA market has witnessed moderate growth in recent years, driven by rising incidences of cardiovascular diseases and strokes due to changing lifestyles and growing geriatric population.


The global Tissue Plasminogen Activator Market is estimated to be valued at US$ 2.58 Bn in 2023 and is expected to exhibit a CAGR of 15.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics:
The increasing incidences of cardiovascular diseases is one of the major drivers of the tPA market. Cardiovascular diseases like coronary heart disease, cerebrovascular disease and peripheral artery disease remain the leading causes of mortality worldwide. According to the World Health Organization, cardiovascular diseases accounted for over 17 million deaths in 2015. This rising disease burden has bolstered the demand for tPA to reduce complications associated with cardiovascular events like heart attacks and strokes. Similarly, growing geriatric population is also fueling the market growth as age is a primary risk factor for cardiovascular conditions. The United Nations projects that the number of people aged 65 years or above will reach 1.5 billion by 2050 from 703 million in 2019. Their risk of developing age-related conditions like atherosclerosis is high, thereby necessitating maximum utilization of tPA.
Segment Analysis
The global tissue plasminogen activator market is dominated by the cardiovascular segment which holds around 60% share of the overall market. Cardiovascular diseases such as heart attacks and strokes are the leading cause of death globally. Tissue plasminogen activators help dissolve blood clots and restore blood flow to vital organs in cardiovascular conditions. This makes them the primary treatment option for heart attacks and strokes, driving higher demand and sales within the cardiovascular segment.

PEST Analysis
Political: Governments across major countries are focusing on expanding healthcare access and increasing funding for treatment of lifestyle diseases. This is boosting investments in development of new drugs and therapies for conditions like heart attacks and strokes.
Economic: Rising incidents of cardiovascular diseases due to changing lifestyles and aging population is propelling the economic growth of the tissue plasminogen activator market. The high treatment cost of conditions also increases the market value.
Social: Growing health awareness among public regarding risks of cardiovascular ailments is driving early diagnosis. Social media influence has made people prefer thrombolytic therapies over invasive surgeries.
Technological: Advanced research has enabled development of more targeted thrombolytic drugs with enhanced specificity, quicker clearance, longer half-life and reduced risk of bleeding. Novel drug delivery methods are also expanding the market scope.

Key Takeaways
The Global Tissue Plasminogen Activator Market is expected to witness high growth at a CAGR of 15% during the forecast period of 2023 to 2030.
Regional analysis: North America dominates the global market and is projected to retain its position throughout the forecast period. This can be attributed to established healthcare infrastructure, rising heart disease burden and growing adoption of new technologies in the region.
Key players: Key players operating in the tissue plasminogen activator market are Novocure, Boston Scientific Corporation, OTTO Bock, Wandong Medical, MagVenture, Biomobie and Cerbomed. Novocure holds the leading market share owning to its wide product portfolio and global sales network.
The demand for thrombolytic drugs is fueled by the growing economic burden of cardiovascular diseases worldwide. Technological advancements have augmented the efficacy and safety profile of tissue plasminogen activators. Their preferential use over surgical treatments in conditions like heart attacks and ischemic strokes will further support the market expansion during the forecast period.

Get more insights on this topic: https://www.ukwebwire.com/tissue-plasminogen-activator-market-demand-and-overview/

Comments

Post a Comment

Popular posts from this blog

The Bladder Liners Market Is Estimated To Witness High Growth Owing To Rising Prevalence Of Urinary Incontinence

Image
  Bladder Liners Market Market Overview: Benzodiazepines are a class of psychoactive drugs belonging to the benzodiazepine family. These drugs are prescribed for various medical conditions such as anxiety disorders, panic disorders, insomnia, seizures, alcohol withdrawal syndrome, muscle spasms, and as an anesthesia aid. Some common examples of benzodiazepines include alprazolam, clonazepam, diazepam, and lorazepam. These drugs work by increasing the action of gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the central nervous system. Due to their calming properties, they are widely used to treat insomnia, anxiety, panic attacks, agitation, seizures, muscle spasms, and alcohol withdrawal. Market Dynamics: The Benzodiazepine Drugs Market is primarily driven by the rising prevalence of anxiety disorders worldwide. As per Anxiety and Depression Association of America, anxiety disorders are the most common mental illness in the U.S., affecting nearly 40 million adul
Read more

The Global Electric Powertrain Market Poised for Growth Driven by Sustainable Transportation

Image
  Electric Powertrain Market The global electric powertrain market is seeing rapid adoption as consumers seek more environmentally friendly transportation options. Electric powertrains offer much lower operating costs than internal combustion engines while also being more energy efficient with fewer moving parts. Battery electric vehicles and hybrids containing electric motors and batteries are able to deliver torque instantly for smooth acceleration and regenerative braking that captures kinetic energy to charge the batteries while slowing down. Automakers are developing advanced powertrain technologies that combine smaller, lighter electric motors with improved batteries capable of longer ranges between charges. The global Electric Powertrain Market is estimated to be valued at US$ 94.12 Mn in 2024 and is expected to exhibit a CAGR of 4.9% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: One of the majo
Read more

Poultry Market is Expected to be Flourished by Growing Demand for Protein-Rich Food

Image
Poultry Market The poultry market comprises farming of domesticated birds such as chickens, ducks, turkeys, and geese, primarily for their meat and eggs. Poultry meat is one of the most consumed meats globally owing to its high protein content. Chicken is the most commonly produced meat worldwide, with over 95 million tons produced annually. Poultry farming provides affordable animal protein to consumers while generating income and employment for farmers and allied industries. The global poultry industry includes large integrated production facilities, small commercial farms, and backyard flock operations. Technological advancements have increased efficiency in breeding, hatching, feeding, housing, and disease control. The global poultry market is estimated to be valued at US$ 15.88 billion in 2023 and is expected to exhibit a CAGR of 5.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Dynamics: One of the key driv
Read more